Sheng-Fang Su

Sheng-Fang Su

Auto-generated profile, based on publicly available information

Sheng-Fang Su

Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2023 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
YTYu-Chieh Tsai
Yu-Chieh Tsai
TWTzu-Yin Wang
Tzu-Yin Wang
CHChia-Lang Hsu
Chia-Lang Hsu
WLWei-Chou Lin
Wei-Chou Lin
JCJyun-Yu Chen
Jyun-Yu Chen
SSSheng-Fang Su
Sheng-Fang Su
Background: Although trimodality therapy resecting tumours followed by chemoradiotherapy is emerged for muscle-invasive bladder cancer (MIBC), chemotherapy produces toxicities. Histone deacetylase inhibitors have been identified as an effective strategy to enhance cancer radiotherapy (RT).Methods: We examined the role of HDAC6 and specific inhibition of HDAC6 on BC radiosensitivity by performing transcriptomic analysis and mechanism study.Results: HDAC6 knockdown or HDAC6 inhibitor (HDAC6i) tubacin exerted a radiosensitizing effect, including decreased clonogenic survival, increased H3K9ac andα-tubulin acetylation, and accumulated γH2AX, which are similar to the effect of panobinostat, a pan-HDACi, on irradiated BC cells. Transcriptomics of shHDAC6-transduced T24 under irradiation showed that shHDAC6 counteracted RT-induced mRNA expression of CXCL1, SERPINE1, SDC1 and SDC2, which are linked to cell migration, angiogenesis and metastasis. Moreover, tubacin significantly suppressed RT-induced CXCL1 and radiation-enhanced invasion/migration, whereas panobinostat elevated RT-induced CXCL1 expression and invasion/migration abilities. This phenotype was significantly abrogated by anti-CXCL1 antibody, indicating the key regulator of CXCL1 contributing to BC malignancy. Immunohistochemical evaluation of tumours from urothelial carcinoma patients supported the correlation between high CXCL1 expression and reduced survival.Conclusion: Unlike pan-HDACi, the selective HDAC6i can enhance BC radiosensitization and effectively inhibit RT-induced oncogenic CXCL1-Snail-signalling, thus further advancing its therapeutic potential with RT.

1 November 2021 in JCO Precision Oncology
Verified
Journal Article
Open access
SSSheng-Fang Su
Sheng-Fang Su
CLChia-Hsin Liu
Chia-Hsin Liu
CCChiou-Ling Cheng
Chiou-Ling Cheng
CHChao-Chi Ho
Chao-Chi Ho
TYTsung-Ying Yang
Tsung-Ying Yang
KLKer-Chau Li
Ker-Chau Li
PURPOSE: Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) show efficacy in treating patients with lung adenocarcinoma with EGFR-activating mutations. However, a significant subset of targeted patients fail to respond. Unlike acquired resistance (AR), intrinsic resistance (IR) remains poorly understood. We investigated whether epigenomic factors contribute to patient-to-patient heterogeneity in the EGFR-TKI response and aimed to characterize the IR subpopulation that obtains no benefit from EGFR-TKIs. PATIENTS AND METHODS: We conducted genome-wide DNA methylation profiling of 79 tumors sampled from patients with advanced lung adenocarcinoma before they received EGFR-TKI treatment and analyzed the patient responses. Pyrosequencing was performed in a validation cohort of 163 patients with EGFR-activating mutations. RESULTS: A DNA methylation landscape of 216 CpG sites with differential methylation was established to elucidate the association of DNA methylation with the characteristics and EGFR-TKI response status of the patients. Functional analysis of 37 transcription-repressive sites identified the enrichment of transcription factors, notably homeobox ( HOX) genes. DNA methylation of HOXB9 (cg13643585) in the enhancer region yielded 88% sensitivity for predicting drug response (odds ratio [OR], 6.64; 95% CI, 1.98 to 25.23; P = .0009). Pyrosequencing validated that HOXB9 gained methylation in patients with a poor EGFR-TKI response (OR, 3.06; 95% CI, 1.13 to 8.19; P = .019). CONCLUSION: Our data suggest that homeobox DNA methylation could be a novel tumor cellular state that can aid the precise categorization of tumor heterogeneity in the study of IR to EGFR-TKIs. We identified, for the first time, an epigenomic factor that can potentially complement DNA mutation status in discriminating patients with lung adenocarcinoma who are less likely to benefit from EGFR-TKI treatment, thereby leading to improved patient management in precision medicine.

16 August 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
SSSheng-Fang Su
Sheng-Fang Su
HHHao Ho
Hao Ho
JLJia-Hua Li
Jia-Hua Li
MWMing-Fang Wu
Ming-Fang Wu
HWHsu-Chieh Wang
Hsu-Chieh Wang
KLKer-Chau Li
Ker-Chau Li
Unlike the better-studied aberrant epigenome in the tumor, the clinicopathologic impact of DNA methylation in the tumor microenvironment (TME), especially the contribution from cancer-associated fibroblasts (CAFs), remains elusive. CAFs exhibit profound patient-to-patient tumorigenic heterogeneity. We asked whether such heterogeneity may be exploited to quantify the level of TME malignancy. We developed a robust and efficient methylome/transcriptome co-analytical system for CAFs and paired normal fibroblasts (NFs) from non–small-cell lung cancer patients. We found 14,781 CpG sites of CAF/NF differential methylation, of which 3,707 sites showed higher methylation changes in ever-smokers than in nonsmokers. Concomitant CAF/NF differential gene expression analysis pointed to a subset of 54 smoking-associated CpG sites with strong methylation-regulated gene expression. A methylation index that summarizes the β values of these CpGs was built for NF/CAF discrimination (MIND) with high sensitivity and specificity. The potential of MIND in detecting premalignancy across individual patients was shown. MIND succeeded in predicting tumor recurrence in multiple lung cancer cohorts without reliance on patient survival data, suggesting that the malignancy level of TME may be effectively graded by this index. Precision TME grading may provide additional pathological information to guide cancer prognosis and open up more options in personalized medicine.

29 March 2010 in Quality and Safety in Health Care
Verified
Journal Article
Closed access
PDF file
Kuei-Hsien ChenKuei-Hsien Chen
Kuei-Hsien Chen
LCL. R. Chen
L. R. Chen
SSS. Su
S. Su
Objective To investigate the effectiveness of interventions to prevent falls designed through hazard analysis using root cause analysis. Design Prospective longitudinal study. Under preceding root cause analysis, root factors were classified into four major categories: environment and facilities, procedure, individual, and communication. Among them, communication, environment and facilities were recognised as the most vital factors to facilitate intervention accordingly. The fall prevention programme included first intervention with adding live demonstrations and offering a printed education sheet, and second intervention with adjusting rails at the bedside and in the ward, placing anti-sliding pads on the floors of the bathrooms and enhancing local light in the bathrooms. Setting Two large hospitals in Taiwan, both with an average of 200 or more childbirths per month, with an intervention group and a non-intervention control group. Participants 2460 (intervention group) and 2451(control group) participants. Main outcome measures The number of postpartum falls within 6 months before and after intervention, and the incidence after adjustment by patient-days. Results In the intervention group, the incidence of postpartum falls before intervention was 14.24 per 1000 patient-days and dropped to 6.02 per 1000 patient-days after intervention. The control group showed no marked decline in incidence with a rate of 13.72 and 14.05 per 1000 patient-days, respectively. Using the Mantel–Haenszel test to compare the incident rate, there were significant differences (p<0.001) between the incidence of the intervention group before and after intervention; and between the latter and each incidence of the control group. Conclusions This study provides direct evidence that root cause analysis can be adopted in analysing causes and in formulating interventions to reduce the incidence of postpartum falls and improve patient safety.